Sanofi Reports Decline in Flu Vaccine Sales
Sanofi SA reported a decline in vaccine sales for the third quarter of 2025, citing reduced vaccination rates and increased pricing competition in Europe and the United States. The company’s legacy vaccine business dropped nearly eight percent to €3.36 billion (US$3.9 billion), while influenza and COVID-19 shot sales fell 17 percent to €1.53 billion (US$1.78 […]
FDA Plans for Expedited Licensure Approval of GSK’s Autism Drug
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA), in collaboration with the British pharmaceutical company GSK plc, announced plans to fast-track licensure of leucovorin calcium tablets. The drug, which GSK calls Wellcovorin, has long been used to treat anemia and counteract the effects of chemotherapy, The FDA will approve it for use […]
Johnson & Johnson Liable for Nearly $1 Billion in Damages for Cancer-Causing Baby Powder
Earlier this month, a jury in Los Angeles, found Johnson & Johnson, Inc. (J&J) was liable for damages in the amount of $966 million dollars to the family of a long-time consumer of its baby talcum powder. The jury concluded that the pharmaceutical giant was liable for its dangerous talcum powder product which caused the […]
Pharmacists Instructed to Combat “Mistrust” in Vaccination and Increase Vaccine Uptake
In an interview with Drug Topics, Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, emphasized that all pharmacy employees, including frontline staff like pharmacy technicians and cashiers, must take an active role in building trust with patients and providing clear information about vaccines.1 According to Zaibak, public distrust in routine vaccination, commonly referred to as vaccine […]
U.S. Withdraws Financial Support from Pharma’s Arm GAVI
The U.S. government has withdrawn a $1.2 billion pledge to the Global Alliance for Vaccines and Immunization (GAVI) originally made by the Biden administration. GAVI, which is officially known as Gavi, The Vaccine Alliance, is a public-private multilateral funding partnership launched in 2000 by the pharmaceutical industry, governments and private institutions and philanthropic organizations to […]
Nomination of Susan Monarez for CDC Director Advances to Full Senate
(photo courtesy ARPA-H) On July 9, 2025, the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) voted 12 to 11 to advance the nomination of Susan Monarez to be director of the Centers for Disease Control and Prevention (CDC). Monarez, who holds a doctorate degree in microbiology and immunology and has been serving […]